NFKB1 and cancer: This leads to elevated conversion to lactate, which feeds back on NF-κB and subsequently drives PD-L1 expression.291 These findings underlined the pivotal role of the NF-κB pathway in linking metabolic remodulations with inflammasome-driven cellular responses in cancer.